ArticleJournal of the National Cancer Institute2026

Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer.

Daniela Ottaviani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.